Categories
Part D Prescription Drug

The 2021 Medicare Part D Drug Plan Phases

During the first quarter of the new year I often receive this question: “Dan, I went to refill my prescription and was quoted almost double what I paid in December.” Here’s why. Medicare Part D Prescription Drug plans reset each year on January 1 and benefit levels start again at the first of four phases. […]

Categories
Part D Prescription Drug

COVID-19 Vaccination Update

I have received several inquiries these past few days as New York State followed the updated CDC guidelines and announced that anyone over the age of 65 is now eligible to receive the COVID-19 vaccine. (This was one day after announcing that those over 75 were eligible, and that the 65-74 age group was probably […]

Categories
Medicare Part C Medicare Advantage Part D Prescription Drug

What If I Missed the Medicare AEP Deadline?

This year’s Medicare Annual Enrollment Period (October 15 through December 7) was a busy time and we are grateful for the scores of individuals and couples who permitted our team of agent advisors to help with their 2021 Part C Medicare Advantage or Part D Prescription drug plan selection. (The December 7 deadline did not […]

Categories
Part D Prescription Drug

Does Medicare Pay for The Shingles Vaccine?

Unlike some common vaccines, like those for the flu, hepatitis B and pneumonia, shingles shots are not covered under Original Medicare Parts A or B. Medicare coverage for the two commercially available shingles vaccines, Shingrix and Zostavax, is provided only if you are enrolled in a stand-alone Part D drug plan or a Medicare Advantage […]

Categories
Case Studies Part D Prescription Drug

New York State EPIC and Mary – a case study

“… a huge thanks for cluing us in to the EPIC ..program.” “…we now estimate yearly savings to be $7,000+/-”  “…we’d never heard of this program until one of your newsletter emails..” When Mary became eligible for Medicare I helped her enroll in the Medicare Supplement Plan G she selected as secondary to Original Medicare. […]

Categories
Case Studies Part C Medicare Advantage Part D Prescription Drug

“Thank you for helping me change my insurance!”

This month I received this wonderful thank you note from Nancy. She had recently relocated and needed to find new doctors along with a Medicare Advantage plan covering those doctors and her medications. Nancy was concerned that she would have to remain on her current plan and wait until the Annual Open Enrollment Period in […]

Categories
Medicare A & B Medicare supplement Part D Prescription Drug

What is the “Medicare Savings Program?”

Individuals enrolled in Medicare Parts A and B may apply for the Medicare Savings Program. If eligible you will receive help paying the Medicare Part B premium, currently $135.50. In some instances, (QMB) the program will pay your Part A and Part B deductible and co-insurance amounts. (And possibly a percentage of your Part C […]

Categories
Part D Prescription Drug

Eli Lilly Will Sell Half-Price Version of Humalog Insulin

This is a step in the right direction. Drug manufacturer Eli Lilly is introducing Insulin Lispro, a generic version of Humalog – an insulin to treat Type 2 diabetes. However don’t expect for this to appear on your health insurance generic drug formulary anytime soon. “…those with drug coverage will either experience no change or […]

Categories
Case Studies Part D Prescription Drug

A Medicare Advantage case study.

If you, a loved one, friend or neighbor has experienced “sticker shock” with your Medicare Part D prescription drug co-payment, the following case study may interest you. Earlier this week, I received this message from an Albany New York County couple: “We were talking with our neighbor Kathy about the sudden and unaffordable cost of […]

Categories
Part D Prescription Drug

The $9 billion in Extra Cash From Medicare

On January 4, 2019 the Wall Street Journal published a powerful article written by Joseph Walker and Christopher Weaver describing how Medicare Part D insurers kept $9.1 billion more in taxpayer funds than they would have had their estimates been accurate from 2006 to 2015. In the WSJ  article, the writers do a deep dive […]